Can we incorporate MRD assessment into clinical practice in AML?
Author:
Funder
NCRI
Publisher
Elsevier BV
Subject
Clinical Biochemistry,Oncology
Reference41 articles.
1. Acute myeloid leukemia;Döhner;N Engl J Med,2015
2. Complete remissions (CRs) with Azacitidine regimens compared to CRs with 7+3 induction chemotherapy and the effect on overall survival;Othus;Blood,2016
3. Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia;Inaba;J Clin Oncol,2012
4. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Döhner;Blood,2017
5. Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for ‘prime time’?;Grimwade;Blood,2014
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Minimal residual disease monitoring in acute myeloid leukemia: Focus on MFC‐MRD and treatment guidance for elderly patients;European Journal of Haematology;2024-02-11
2. Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling;Leukemia Research;2022-12
3. Identification of Leukemia-Associated Immunophenotypes by Databaseguided Flow Cytometry Provides a Highly Sensitive and Reproducible Strategy for the Study of Measurable Residual Disease in Acute Myeloblastic Leukemia;Cancers;2022-08-19
4. De novo acute myeloid leukemia harboring concomitant t(8;21)(q22;q22);RUNX1::RUNX1T1 and BCR::ABL1 (p190 minor transcript);Journal of Hematopathology;2022-07-31
5. Clinical Impact of Measurable Residual Disease in Acute Myeloid Leukemia;Cancers;2022-07-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3